.

A PSA-activated protoxin (PRX302) administered transperineally to men with BPH is well tolerated and induces reduction in prostate volume and symptomatic relief

LAUR Repository

Show simple item record

dc.contributor.author Abi-Habib, Ralph J.
dc.contributor.author Pommerville, Peter J.
dc.contributor.author Steinhoff, Gary
dc.date.accessioned 2018-06-13T09:40:28Z
dc.date.available 2018-06-13T09:40:28Z
dc.date.copyright 2009 en_US
dc.identifier.issn 1527-3792 en_US
dc.identifier.uri http://hdl.handle.net/10725/8038
dc.language.iso en en_US
dc.title A PSA-activated protoxin (PRX302) administered transperineally to men with BPH is well tolerated and induces reduction in prostate volume and symptomatic relief en_US
dc.type Article en_US
dc.description.version Published en_US
dc.author.school SAS en_US
dc.author.idnumber 200901419 en_US
dc.author.department Natural Sciences en_US
dc.description.embargo N/A en_US
dc.relation.journal The journal of Urology en_US
dc.journal.volume 181 en_US
dc.journal.issue 4 en_US
dc.article.pages 704 en_US
dc.identifier.ctation Pommerville, P. J., Steinhoff, G., Denmeade, S., Merchant, R., Buckley, T., & Abi-Habib, R. J. (2009). A PSA-ACTIVATED PROTOXIN (PRX302) ADMINISTERED TRANSPERINEALLY TO MEN WITH BPH IS WELL TOLERATED AND INDUCES REDUCTION IN PROSTATE VOLUME AND SYMPTOMATIC RELIEF. The Journal of Urology, 181(4), 704. en_US
dc.author.email ralph.abihabib@lau.edu.lb en_US
dc.identifier.tou http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php en_US
dc.identifier.url https://www-clinicalkey-com.ezproxy.lau.edu.lb:2443/service/content/pdf/watermarked/1-s2.0-S0022534709619686.pdf?locale=en_US en_US
dc.author.affiliation Lebanese American University en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search LAUR


Advanced Search

Browse

My Account